Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,841,255
-
Number of holders
-
570
-
Total 13F shares, excl. options
-
76,358,980
-
Shares change
-
-402,133
-
Total reported value, excl. options
-
$11,868,339,082
-
Value change
-
-$66,961,009
-
Put/Call ratio
-
111%
-
Number of buys
-
217
-
Number of sells
-
-282
-
Price
-
$155.49
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q3 2017
638 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q3 2017.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 570 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76,358,980 shares
of 80,841,255 outstanding shares and own 94% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9,186,404 shares), BlackRock Inc. (7,156,245 shares), BAMCO INC /NY/ (4,726,336 shares), Fundsmith LLP (4,444,708 shares), STATE STREET CORP (3,712,459 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,299,667 shares), BLAIR WILLIAM & CO/IL (1,781,760 shares), Neuberger Berman Group LLC (1,721,588 shares), RENAISSANCE TECHNOLOGIES LLC (1,589,800 shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (1,311,460 shares).
This table shows the top 570 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.